BPR | Part 4
Part 1 introduced the Biocidal Products Regulation (BPR), explained what defines a biocide, how Article 95 works, what a Competent Authority is, and how Product Type (PT) groups help determine product classification. We also looked at a practical PT2 example.
Part 2 included more examples, including PT1 and dog shampoos, preserving non-biocidal products.
Part 3 explained borders with other laws, and who DEFRA are.
So welcome back - let’s continue!
What is a Biocidal Product Family?
A biocidal product family (BPF) under the Biocidal Products Regulation (BPR) allows similar biocidal products to be grouped together for authorisation. This simplifies the process, saving time and reducing costs, while ensuring compliance.
What Defines a Biocidal Product Family?
A BPF consists of products that:
- Share the same active substance(s) and intended use.
- Have similar formulations, with only minor variations (e.g., in fragrance, dye, or concentration).
- Present the same level of risk to human health, animals, and the environment.
Example of a Biocidal Product Family:
Imagine a company producing surface disinfectants:
- Product A: A ready-to-use disinfectant with lemon fragrance and yellow dye.
- Product B: A blue-coloured disinfectant with no added fragrance.
- Product C: A 10-fold concentrated disinfectant, designed to be diluted by the end user.
These products share the same active ingredient (e.g., benzalkonium chloride) and similar risks, but their variations in colour, fragrance, and concentration do not affect safety or efficacy. They can be grouped into a single biocidal product family for authorisation.
Benefits of a BPR Family:
Benefits of a BPR Family:
- Cost Savings: One application covers the entire family, avoiding multiple costly submissions.
- Time Efficiency: A single regulatory review speeds up approval.
- Flexibility: Adjust colour or fragrance without needing a new authorisation, as long as variations remain within family parameters.
Key Takeaway:
If your surface disinfectants share similar formulations and risks, consider applying as a biocidal product family. This approach ensures compliance, saves costs, and simplifies regulatory management.
